WINDTREE THERAPEUTICS INC (WINT) Stock Price, Quote, News and Overview
NASDAQ:WINT - Nasdaq - US97382D5014 - Common Stock - Currency: USD
WINT Quote, Performance and Key Statistics
WINDTREE THERAPEUTICS INC
NASDAQ:WINT (2/10/2025, 8:00:02 PM)
Premarket: 0.136 -0.01 (-3.82%)0.1414
+0.02 (+20.44%)
The current stock price of WINT is 0.1414 USD. In the past month the price decreased by -44.59%. In the past year, price decreased by -97.79%.
WINT Latest News and Analysis
Friday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline
The Company’s oncology aPKCi inhibitor is a novel, first in class drug candidate...
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
WARRINGTON, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
All-Stock Acquisition Strategy Targets Multiple Small Companies with FDA-Approved Products to Drive Growth and Shareholder Value...
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
WARRINGTON, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
WINT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.81 | 336.36B | ||
| AMGN | AMGEN INC | 14.87 | 158.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1620.59 | 121.03B | ||
| GILD | GILEAD SCIENCES INC | 21.55 | 118.99B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.13 | 75.86B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.35B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.63B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.41B | ||
| NTRA | NATERA INC | N/A | 22.73B | ||
| BIIB | BIOGEN INC | 8.73 | 20.77B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.18 | 15.43B |
Related stock screener links
About WINT
Company Profile
Windtree Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Warrington, Pennsylvania and currently employs 15 full-time employees. Windtree Therapeutics, Inc. is a biotechnology company. The firm is focused on advancing early and late-stage therapies for critical conditions and diseases. The Company’s portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. Its lead product candidate, istaroxime, is a dual-acting agent being developed to increase blood pressure and improve cardiac function in patients with cardiogenic shock and to improve cardiac function in patients with acute heart failure (AHF) and reverse the hypotension and hypoperfusion associated with heart failure that deteriorates to cardiogenic shock. The firm also has a licensing business model with partnership out-licenses in place.
Company Info
WINDTREE THERAPEUTICS INC
2600 Kelly Rd Ste 100
Warrington PENNSYLVANIA 18976 US
CEO: Craig E. Fraser
Employees: 20
Company Website: https://windtreetx.com/
Investor Relations: http://windtreetx.investorroom.com/
Phone: 12154889300
WINT FAQ
What is the stock price of WINT?
The current stock price of WINT is 0.1414 USD.
What is the symbol for WINDTREE THERAPEUTICS INC stock?
The exchange symbol of WINDTREE THERAPEUTICS INC is WINT and it is listed on the Nasdaq exchange.
On which exchange is WINT stock listed?
WINT stock is listed on the Nasdaq exchange.
Is WINT a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for WINT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of WINT.
Does WINT stock pay dividends?
WINT does not pay a dividend.
What is the Price/Earnings (PE) ratio of WINT?
WINT does not have a PE ratio as the earnings reported over the last twelve months were negative (-8).
What is the Short Interest ratio of WINT stock?
The outstanding short interest for WINT is 10.15% of its float.
WINT Technical Analysis
WINT Financial Highlights
Over the last trailing twelve months WINT reported a non-GAAP Earnings per Share(EPS) of -8. The EPS decreased by 98.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.17% | ||
| ROE | -163.47% | ||
| Debt/Equity | 0.12 |
WINT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to WINT. The Buy consensus is the average rating of analysts ratings from 6 analysts.